361 related articles for article (PubMed ID: 25466464)
1. Surface engineering of silica nanoparticles for oral insulin delivery: characterization and cell toxicity studies.
Andreani T; Kiill CP; de Souza AL; Fangueiro JF; Fernandes L; Doktorovová S; Santos DL; Garcia ML; Gremião MP; Souto EB; Silva AM
Colloids Surf B Biointerfaces; 2014 Nov; 123():916-23. PubMed ID: 25466464
[TBL] [Abstract][Full Text] [Related]
2. Effect of mucoadhesive polymers on the in vitro performance of insulin-loaded silica nanoparticles: Interactions with mucin and biomembrane models.
Andreani T; Miziara L; Lorenzón EN; de Souza AL; Kiill CP; Fangueiro JF; Garcia ML; Gremião PD; Silva AM; Souto EB
Eur J Pharm Biopharm; 2015 Jun; 93():118-26. PubMed ID: 25843239
[TBL] [Abstract][Full Text] [Related]
3. Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: in vitro and in vivo assessment.
Bagre AP; Jain K; Jain NK
Int J Pharm; 2013 Nov; 456(1):31-40. PubMed ID: 23994363
[TBL] [Abstract][Full Text] [Related]
4. Preparation and characterization of PEG-coated silica nanoparticles for oral insulin delivery.
Andreani T; de Souza AL; Kiill CP; Lorenzón EN; Fangueiro JF; Calpena AC; Chaud MV; Garcia ML; Gremião MP; Silva AM; Souto EB
Int J Pharm; 2014 Oct; 473(1-2):627-35. PubMed ID: 25089510
[TBL] [Abstract][Full Text] [Related]
5. Enhancing Stability and Mucoadhesive Properties of Chitosan Nanoparticles by Surface Modification with Sodium Alginate and Polyethylene Glycol for Potential Oral Mucosa Vaccine Delivery.
Amin MK; Boateng JS
Mar Drugs; 2022 Feb; 20(3):. PubMed ID: 35323455
[No Abstract] [Full Text] [Related]
6. A review of biodegradable polymeric systems for oral insulin delivery.
Luo YY; Xiong XY; Tian Y; Li ZL; Gong YC; Li YP
Drug Deliv; 2016 Jul; 23(6):1882-91. PubMed ID: 26066036
[TBL] [Abstract][Full Text] [Related]
7. Oral delivery of insulin from alginate/chitosan crosslinked by glutaraldehyde.
Tahtat D; Mahlous M; Benamer S; Khodja AN; Oussedik-Oumehdi H; Laraba-Djebari F
Int J Biol Macromol; 2013 Jul; 58():160-8. PubMed ID: 23567292
[TBL] [Abstract][Full Text] [Related]
8. Probing insulin's secondary structure after entrapment into alginate/chitosan nanoparticles.
Sarmento B; Ferreira DC; Jorgensen L; van de Weert M
Eur J Pharm Biopharm; 2007 Jan; 65(1):10-7. PubMed ID: 17101268
[TBL] [Abstract][Full Text] [Related]
9. Vitamin B12 functionalized layer by layer calcium phosphate nanoparticles: A mucoadhesive and pH responsive carrier for improved oral delivery of insulin.
Verma A; Sharma S; Gupta PK; Singh A; Teja BV; Dwivedi P; Gupta GK; Trivedi R; Mishra PR
Acta Biomater; 2016 Feb; 31():288-300. PubMed ID: 26685755
[TBL] [Abstract][Full Text] [Related]
10. Preparation, characterization, and evaluation in vivo of Ins-SiO₂-HP55 (insulin-loaded silica coating HP55) for oral delivery of insulin.
Zhao X; Shan C; Zu Y; Zhang Y; Wang W; Wang K; Sui X; Li R
Int J Pharm; 2013 Sep; 454(1):278-84. PubMed ID: 23830939
[TBL] [Abstract][Full Text] [Related]
11. Effect of pH-responsive alginate/chitosan multilayers coating on delivery efficiency, cellular uptake and biodistribution of mesoporous silica nanoparticles based nanocarriers.
Feng W; Nie W; He C; Zhou X; Chen L; Qiu K; Wang W; Yin Z
ACS Appl Mater Interfaces; 2014 Jun; 6(11):8447-60. PubMed ID: 24745551
[TBL] [Abstract][Full Text] [Related]
12. Alginate/chitosan nanoparticles are effective for oral insulin delivery.
Sarmento B; Ribeiro A; Veiga F; Sampaio P; Neufeld R; Ferreira D
Pharm Res; 2007 Dec; 24(12):2198-206. PubMed ID: 17577641
[TBL] [Abstract][Full Text] [Related]
13. pH-sensitive chitosan/alginate core-shell nanoparticles for efficient and safe oral insulin delivery.
Mukhopadhyay P; Chakraborty S; Bhattacharya S; Mishra R; Kundu PP
Int J Biol Macromol; 2015 Jan; 72():640-8. PubMed ID: 25239194
[TBL] [Abstract][Full Text] [Related]
14. Development of hydrophilic nanocarriers for the charged form of the local anesthetic articaine.
Silva de Melo NF; Campos EV; Gonçalves CM; de Paula E; Pasquoto T; de Lima R; Rosa AH; Fraceto LF
Colloids Surf B Biointerfaces; 2014 Sep; 121():66-73. PubMed ID: 24934456
[TBL] [Abstract][Full Text] [Related]
15. Effects of surface modification and size on oral drug delivery of mesoporous silica formulation.
Wang Y; Cui Y; Zhao Y; Zhao Q; He B; Zhang Q; Wang S
J Colloid Interface Sci; 2018 Mar; 513():736-747. PubMed ID: 29220688
[TBL] [Abstract][Full Text] [Related]
16. Development of acid-resistant alginate/trimethyl chitosan nanoparticles containing cationic β-cyclodextrin polymers for insulin oral delivery.
Mansourpour M; Mahjub R; Amini M; Ostad SN; Shamsa ES; Rafiee-Tehrani M; Dorkoosh FA
AAPS PharmSciTech; 2015 Aug; 16(4):952-62. PubMed ID: 25604700
[TBL] [Abstract][Full Text] [Related]
17. Polymer-based nanoparticles for oral insulin delivery: Revisited approaches.
Fonte P; Araújo F; Silva C; Pereira C; Reis S; Santos HA; Sarmento B
Biotechnol Adv; 2015 Nov; 33(6 Pt 3):1342-54. PubMed ID: 25728065
[TBL] [Abstract][Full Text] [Related]
18. Biopolymeric alginate-chitosan nanoparticles as drug delivery carriers for cancer therapy.
Bhunchu S; Rojsitthisak P
Pharmazie; 2014 Aug; 69(8):563-70. PubMed ID: 25158565
[TBL] [Abstract][Full Text] [Related]
19. Development of a novel drug delivery system: chitosan nanoparticles entrapped in alginate microparticles.
Garrait G; Beyssac E; Subirade M
J Microencapsul; 2014; 31(4):363-72. PubMed ID: 24697173
[TBL] [Abstract][Full Text] [Related]
20. Insulin-loaded alginic acid nanoparticles for sublingual delivery.
Patil NH; Devarajan PV
Drug Deliv; 2016; 23(2):429-36. PubMed ID: 24901208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
